Skip to content
PubMed This is a summary of 19 peer-reviewed journal articles Updated
Cardiology

Understanding Your Diagnosis of Aortic Valve Stenosis

At a Glance

Aortic stenosis is a fixed narrowing of the heart’s aortic valve, often caused by calcium buildup. Medicines cannot reverse established narrowing, so a Heart Team uses symptoms, ultrasound findings, overall health, and personal goals to choose monitoring or valve replacement.

Receiving a diagnosis of aortic stenosis (AS) often brings a mix of emotions. For some, it is a moment of relief—finally having a name for the fatigue or breathlessness that felt like “just getting older” [1]. For others, it is a shock to learn that a heart valve is failing, especially if you do not feel “sick” yet [1].

This page is designed to help you orient yourself to what this diagnosis means, how it works mechanically, and why your care will likely involve a specialized group of experts known as a Heart Team.

A Mechanical Problem, Not a Chemical One

The most important thing to understand about aortic stenosis is that it is a structural, mechanical issue [2]. Your aortic valve is the “front door” of your heart; it must open wide to let oxygen-rich blood pump out to the rest of your body. In calcific aortic stenosis, calcium deposits build up on the valve leaflets, making them stiff and heavy [2][3].

Think of it like a door with rusted, calcium-encrusted hinges. No matter how hard the heart (the “pump”) pushes, the door can only open a crack. This creates a “fixed” obstruction that forces your heart to work much harder to move blood through a smaller opening [2][3].

The “Melt” Misconception

A common hope among patients is that a change in diet or a new medication can “melt” or dissolve the calcium on the valve, similar to how some medications treat cholesterol in the arteries. However, research has shown that no medication—including statins and bone-density drugs—has been proven to reverse established valve calcification [4][5].

Do not stop taking your prescribed medications. While you may still take medications for blood pressure or cholesterol to protect your overall cardiovascular health, they cannot fix the mechanical narrowing of the valve [6]. Once the valve is significantly narrowed, the only effective way to restore normal blood flow is to physically repair or replace the valve [7][8].

Understanding the Numbers

Aortic stenosis is one of the most common valve diseases, and its prevalence increases as we age:

  • General Population: Roughly 0.4% of all people have calcific AS [9].
  • Over Age 65: The rate jumps to approximately 1.7% [9].
  • Bicuspid Aortic Valve (BAV): About 1–2% of the population is born with two valve leaflets instead of the usual three, which can cause the valve to wear out and narrow earlier in life [10].

Why You Need a Heart Team

Because AS is complex and involves several treatment paths, modern guidelines recommend a Heart Team approach [11][12]. This is a multidisciplinary group of specialists who review your case together to ensure you get the right treatment at the right time. Your team may include:

  • Interventional Cardiologists: Experts in minimally invasive, catheter-based procedures.
  • Cardiac Surgeons: Experts in traditional and minimally invasive valve surgery.
  • Imaging Specialists: Doctors who use advanced echocardiograms and CT scans to measure the exact size and shape of your valve [12][13].
  • Geriatricians or Nurses: To evaluate your overall strength and recovery goals [13][14].

The Heart Team is necessary because there is no “one-size-fits-all” answer. They weigh factors like your age, the shape of your heart, other health conditions, and your personal lifestyle goals to decide whether you are best suited for Transcatheter Aortic Valve Replacement (TAVR), Surgical Aortic Valve Replacement (SAVR), or continued monitoring [15][16].

Living with the Diagnosis

If your doctor tells you that your stenosis is “mild” or “moderate,” you may enter a phase called clinical surveillance [17]. During this time, your team will use echocardiography (an ultrasound of the heart) to track how fast the narrowing is progressing and how your heart muscle is responding to the extra work [18][17]. Intervals vary depending on severity, often 3 to 5 years for mild, 1 to 2 years for moderate, and 6 to 12 months for severe asymptomatic AS [17].

It is normal to feel anxious about “waiting,” but this monitoring ensures that if the valve reaches a critical point, you can move toward a procedure before your heart muscle sustains lasting damage [19][7]. However, if severe AS becomes symptomatic, prompt assessment for a valve replacement is needed. Your role during this time is to stay in close communication with your team about any changes in how you feel during daily activities.

Common questions in this guide

What does an aortic stenosis diagnosis mean?
Aortic stenosis means the aortic valve opening has become too narrow, often because calcium deposits have made the valve flaps stiff. The heart must work harder to push blood through the smaller opening, so symptoms such as fatigue or shortness of breath can develop.
Can diet or medicine remove calcium from a narrowed aortic valve?
No medicine, including cholesterol-lowering statins or bone-strengthening drugs, has been proven to reverse established calcium buildup on the valve. Blood pressure and cholesterol medicines may still protect your overall heart health but do not open the narrowed valve, so do not stop them without speaking with your clinician.
How is the severity of aortic stenosis followed?
An echocardiogram, which is an ultrasound of the heart, measures the valve and shows how the heart muscle is responding. Follow-up may be every 3 to 5 years for mild disease, every 1 to 2 years for moderate disease, or every 6 to 12 months for severe disease without symptoms; your clinician may adjust this based on your symptoms and findings.
What is a Heart Team, and why do I need one?
A Heart Team is a group that may include an interventional cardiologist, cardiac surgeon, imaging specialist, and sometimes a geriatrician or nurse. The team reviews your age, valve and heart anatomy, other health conditions, recovery goals, and lifestyle priorities to recommend the most suitable plan.
How will my doctors choose between TAVR, SAVR, and monitoring?
The choice depends on factors such as your age, heart and valve anatomy, other health conditions, the severity of the narrowing, your symptoms, and your recovery or lifestyle goals. The team may recommend catheter-based transcatheter aortic valve replacement (TAVR), surgical aortic valve replacement (SAVR), or continued monitoring.
What changes should I report after an aortic stenosis diagnosis?
Tell your care team about new or worsening shortness of breath, fatigue, or difficulty keeping up with usual activities. These changes can affect how urgently you need an assessment, particularly when the narrowing is severe, so contact your team promptly if symptoms appear or worsen.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on aortic valve stenosis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my echocardiogram, is my aortic stenosis considered mild, moderate, or severe?
  2. 2.Is my valve calcification caused by age-related wear or a bicuspid (two-leaflet) valve?
  3. 3.Has my heart muscle already begun to thicken or change shape due to the extra pressure?
  4. 4.Since this is a mechanical problem, what signs will tell us that my heart is no longer able to compensate for the narrowing?
  5. 5.How does our hospital's 'Heart Team' work together to review my specific case?
  6. 6.What are the pros and cons of monitoring the valve (watchful waiting) versus planning an intervention now?

References

References (19)
  1. 1

    Aortic valve stenosis awareness in Austria-results of a nationwide survey in 1001 subjects.

    Hengstenberg C, Thoenes M, Bramlage P, et al.

    Wiener medizinische Wochenschrift (1946) 2020; (170(5-6)):141-149 doi:10.1007/s10354-019-00708-2.

    PMID: 31541366
  2. 2

    Comparative Analysis of TAVR (Transcatheter Aortic Valve Replacement) and Surgical Valve Replacement for Low-Risk Patients.

    Topalkatti U, Prasad RC, Koppu BR, et al.

    Cureus 2023; (15(10)):e47234 doi:10.7759/cureus.47234.

    PMID: 38022257
  3. 3

    Outcomes in Patients With Obstructive Hypertrophic Cardiomyopathy and Concomitant Aortic Stenosis Undergoing Surgical Myectomy and Aortic Valve Replacement.

    Desai MY, Alashi A, Popovic ZB, et al.

    Journal of the American Heart Association 2021; (10(18)):e018435 doi:10.1161/JAHA.120.018435.

    PMID: 34533040
  4. 4

    Effect of Denosumab or Alendronic Acid on the Progression of Aortic Stenosis: A Double-Blind Randomized Controlled Trial.

    Pawade TA, Doris MK, Bing R, et al.

    Circulation 2021; (143(25)):2418-2427 doi:10.1161/CIRCULATIONAHA.121.053708.

    PMID: 33913339
  5. 5

    Lipoprotein(a) and calcific aortic stenosis: from inherited risk marker to therapeutic target.

    Epelde F

    Frontiers in medicine 2026; (13()):1908850 doi:10.3389/fmed.2026.1908850.

    PMID: 42620888
  6. 6

    Calcific Aortic Stenosis: A Review.

    Otto CM, Newby DE, Hillis GS

    JAMA 2024; (332(23)):2014-2026 doi:10.1001/jama.2024.16477.

    PMID: 39527048
  7. 7

    Management of Patients With Aortic Valve Stenosis.

    Kanwar A, Thaden JJ, Nkomo VT

    Mayo Clinic proceedings 2018; (93(4)):488-508 doi:10.1016/j.mayocp.2018.01.020.

    PMID: 29622096
  8. 8

    When the heart becomes suicidal: a case report of severe left ventricular outflow tract obstruction following transcatheter aortic valve implantation.

    Schulz C, Brunner FJ, Pecha S, et al.

    European heart journal. Case reports 2025; (9(5)):ytaf164 doi:10.1093/ehjcr/ytaf164.

    PMID: 40336935
  9. 9

    Calcific aortic stenosis.

    Lindman BR, Clavel MA, Mathieu P, et al.

    Nature reviews. Disease primers 2016; (2()):16006 doi:10.1038/nrdp.2016.6.

    PMID: 27188578
  10. 10

    The American Association for Thoracic Surgery consensus guidelines on bicuspid aortic valve-related aortopathy: Executive summary.

    Borger MA, Fedak PWM, Stephens EH, et al.

    The Journal of thoracic and cardiovascular surgery 2018; (156(2)):473-480 doi:10.1016/j.jtcvs.2017.10.161.

    PMID: 30011756
  11. 11

    Which patients with aortic stenosis should be referred to surgery rather than transcatheter aortic valve implantation?

    Windecker S, Okuno T, Unbehaun A, et al.

    European heart journal 2022; (43(29)):2729-2750 doi:10.1093/eurheartj/ehac105.

    PMID: 35466382
  12. 12

    The International Society for Minimally Invasive Cardiothoracic Surgery Expert Consensus Statement on Transcatheter and Surgical Aortic Valve Replacement in Low- and Intermediate-Risk Patients: A Meta-Analysis of Randomized and Propensity-Matched Studies.

    Thourani VH, Edelman JJ, Holmes SD, et al.

    Innovations (Philadelphia, Pa.) 2021; (16(1)):3-16 doi:10.1177/1556984520978316.

    PMID: 33491539
  13. 13

    Contemporary review of severe aortic stenosis.

    Adams HSL, Ashokkumar S, Newcomb A, et al.

    Internal medicine journal 2019; (49(3)):297-305 doi:10.1111/imj.14071.

    PMID: 30091235
  14. 14

    Aortic stenosis and transcatheter aortic valve implantation in the elderly.

    Rayner C, Adams H

    Australian journal of general practice 2023; (52(7)):458-463 doi:10.31128/AJGP-08-22-6527.

    PMID: 37423243
  15. 15

    Lifetime management of aortic stenosis: A primer for the generalist.

    Safdar NZ, Khedro T, Khan SA, et al.

    The American journal of medicine 2026; (139(10)):1294-1304 doi:10.1016/j.amjmed.2026.04.010.

    PMID: 42000016
  16. 16

    [Diagnosis and treatment of aortic valve stenosis].

    Vogelgesang A, Hasenfuß G, Jacobshagen C

    Der Internist 2018; (59(12)):1279-1290 doi:10.1007/s00108-018-0519-x.

    PMID: 30413846
  17. 17

    Design and rationale of the evaluation of transcatheter aortic valve replacement compared to surveillance for patients with asymptomatic severe aortic stenosis: The EARLY TAVR trial.

    Généreux P, Schwartz A, Oldemeyer B, et al.

    American heart journal 2024; (268()):94-103 doi:10.1016/j.ahj.2023.11.019.

    PMID: 38056546
  18. 18

    Recommendations on the echocardiographic assessment of aortic valve stenosis: a focused update from the European Association of Cardiovascular Imaging and the American Society of Echocardiography.

    Baumgartner H, Hung J, Bermejo J, et al.

    European heart journal. Cardiovascular Imaging 2017; (18(3)):254-275 doi:10.1093/ehjci/jew335.

    PMID: 28363204
  19. 19

    Transcatheter Aortic Valve Replacement versus Surgical Aortic Valve Replacement: A Review of Aortic Stenosis Management.

    Sattar Y, Rauf H, Bareeqa SB, et al.

    Cureus 2019; (11(12)):e6431 doi:10.7759/cureus.6431.

    PMID: 31993269

This page about aortic valve stenosis is for informational purposes only and does not constitute medical advice. Your cardiologist and Heart Team should interpret your echocardiogram and recommend monitoring or treatment for your specific situation.